Purchase Order FA864924P1016

The U.S. Air Force Research Laboratory (AFRL) has awarded a $1,797,867.00 Small Business Innovation Research (SBIR) Phase II contract to Matregenix Inc., a minority-owned and self-certified small disadvantaged business based in Irvine, California. The contract, titled "DERMASPIN: HANDHELD DEVICE FOR CONTACTLESS APPLICATION OF AN ANTIBACTERIAL NANOFIBER MATRIX FOR RAPID WOUND HEALING AT THE POINT-OF-CARE," is a firm fixed-price purchase order with a completion date of May 18, 2026....

The U.S. Air Force Research Laboratory (AFRL) awarded a $72,672.00 Small Business Innovation Research (SBIR) Program Phase I firm-fixed-price purchase order to NKA Bio, Inc. for the development of an anti-shock toxin antibody drug for combat casualty care. The contract has a completion date of December 17, 2024. As a small disadvantaged business, NKA Bio, Inc. was awarded this SBIR Phase I contract to perform research and development related to the delivery of a medical countermeasure for combat...

<p>This is a firm fixed-price purchase order contract awarded by the Air Force Research Laboratory (AFRL) to Code 1 Medical Devices, LLC, a small business, under the SBIR (Small Business Innovation Research) program Phase II. The contract, valued at $1,249,188.00, is for developing solutions to reduce pre-hospital mortality for warfighters with airway obstructions. The contract has a period of performance ending on May 18, 2026.</p>

This is a $1,248,992.00 firm-fixed-price purchase order awarded by the U.S. Air Force Research Laboratory (AFRL) to Matregenix Inc., a minority-owned, self-certified small disadvantaged business based in Irvine, California. The contract is for the development of a biologically-free amino-acid nanofiber product for rotator cuff repair, with an enhanced shelf life and simplified logistics. This award is part of the Small Business Innovation Research (SBIR) Program Phase II and was set aside for...

This is a $1,700,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the Air Force Research Laboratory (AFRL) to Critical Innovations LLC, a small business medical research and development company. The contract is for the development of a fully-qualified manufacturing system for the automated, on-demand, point-of-use production of qualified devices for use in space logistics support by Space Force end users. The contract is a firm-fixed-price purchase order with a...

This is a $1,099,988.88 firm fixed-price contract awarded by the U.S. Army's Research, Development and Engineering Command (DEVCOM) to Parabon NanoLabs, Inc., a small business, on July 11, 2022. The contract is for the development and demonstration of a novel, innovative nanoantibiotics platform to design and synthesize nanocarriers able to effectively deliver antimicrobial peptides to lung tissue to treat pulmonary infections from aerosolized biothreat agents. This contract is part of the...

This is a Firm Fixed Price contract award from the Air Force Research Laboratory (AFRL) to Nanosperse LLC, a small for-profit limited liability company, for the development of an enhanced abrasion resistant coating for composite surfaces used by the U.S. Air Force. The $1,182,231.00 contract is a Small Business Innovation Research (SBIR) Phase II award, with a performance period running through October 28, 2024. Nanosperse has a history of securing SBIR contracts with AFRL and the Naval Sea...

The Department of the Air Force Materiel Command Research Laboratory awarded a $109,921 firm fixed price Small Business Innovation Research Phase I contract to Matregenix Inc. to develop a handheld device for contactless application of an antibacterial nanofiber matrix to rapidly heal wounds at the point-of-care. The total small business set-aside contract has a period of performance through March 2024. Matregenix Inc. is a minority-owned, self-certified small disadvantaged manufacturer...

This is a $1,249,624 firm fixed-price purchase order contract awarded by the Air Force Research Laboratory (AFRL) to Gelsana Therapeutics Inc., a woman-owned small business and HUBZone certified firm. The contract is for the development of novel zwitterionic hydrogels to enhance wound healing in combat-related burn injuries, under the Small Business Innovation Research (SBIR) Program Phase II. This is the second contract award to Gelsana Therapeutics Inc. from AFRL, with the previous Phase I...

This is a Small Business Innovation Research (SBIR) Program Phase I award from the Air Force Research Laboratory (AFRL) to Allkemie LLC, a for-profit limited liability company, for the development of &quot;SPECIAL GRAPHENIC MATERIAL ENHANCED FABRICS FOR BIOLOGICAL WEAPON RESISTANT SUITS&quot;. The firm fixed price contract has a ceiling value of $179,954.92 and an ultimate completion date of March 15, 2025. As an SBIR Phase I award, this contract supports the initial research and development...